GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Short-Term Capital Lease Obligation

Y-Biologics (XKRX:338840) Short-Term Capital Lease Obligation : ₩180 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Short-Term Capital Lease Obligation?

Y-Biologics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩180 Mil.

Y-Biologics's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (₩185 Mil) to Dec. 2023 (₩192 Mil) but then declined from Dec. 2023 (₩192 Mil) to Mar. 2024 (₩180 Mil).

Y-Biologics's annual Short-Term Capital Lease Obligation increased from Dec. 2020 (₩251 Mil) to Dec. 2021 (₩516 Mil) but then declined from Dec. 2021 (₩516 Mil) to Dec. 2022 (₩223 Mil).

Y-Biologics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Y-Biologics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Short-Term Capital Lease Obligation Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial - 262.23 250.91 516.50 223.39

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only 147.41 119.75 184.70 192.47 180.10

Y-Biologics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Y-Biologics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines